RWE and Patient-Centered Outcomes
Widespread availability of real-world data has enabled the generation of evidence and insights that benefit patients, providers, plans, and industry. When that evidence reflects patient outcomes, it provides an invaluable perspective on the consumer experience. Explore our real-world evidence (RWE) analyses and guidance to support your strategic decisions.
COVID-19 Compass
COVID-19 continues to spread nationwide, and individuals with social risk factors and underlying chronic conditions are at highest risk for severe illness.
Webinar: New Data Analytics Approaches for Novel Curative Therapies & APMs
Avalere experts discussed new data analytics and health economics and outcomes research approaches for evaluating key value-based topics in healthcare, including novel curative therapy affordability and access, alternative payment models, and the increasingly important role of real-world evidence in healthcare decision-making.
The Burden and Costs of Recurrent Clostridioides Difficile
Recurring episodes of clostridioides difficile (c diff) create significant added healthcare burden and costs to society and lead to avoidable adverse outcomes in the Medicare population
COVID-19 Complicates Access to Provider-Administered Autoimmune Treatments
The large-scale disruptions resulting from COVID-19 are significantly reshaping how patients receive care. In particular, patients taking infused and injectable drugs administered by a healthcare professional at a physician office, infusion center, or hospital outpatient department now face greater challenges receiving their medications.
Interview: E6 – Get the Facts on COVID-19: Oncology Care and Delivery
Avalere experts discuss how the COVID-19 pandemic has affected oncology care and delivery, and the Oncology Care Model (OCM).
Webinar: Guiding Patients on Care Journeys: Preparing for Shared Decision-Making
Experts from Avalere and the National Patient Advocate Foundation (NPAF) discussed the value of shared decision-making (SDM) and preparing patients and families for navigating their care journeys.
An Update on the Preparation for Shared Decision-Making Tool for Stage III Non-Small Cell Lung Cancer Patients
Avalere published an abstract in the online Journal of National Comprehensive Cancer Network (JNCCN).
Avalere Health Partners with Leading Registry and Analytics Company, Corrona LLC, to Combine Economic and Clinical Outcomes Data for Autoimmune Diseases
The collaboration leverages the Inovalon MORE2 Registry® payer-sourced dataset and Corrona’s platform of clinical registries to enable data-driven insights on the treatment of autoimmune diseases from both clinical and health economic perspectives.
Patient Registries Can Pave the Way to Establishing a Learning Health System
As the shape and scope of America’s learning health system evolves, Avalere partners with industry leaders, engaging multiple stakeholders to formulate patient registry strategies that develop, evaluate, and utilize registry data – and help improve care in real time.
Medication Adherence Rates Low Among Patients with Serious Mental Illness
Avalere research recently published in ClinicoEconomics and Outcomes Research compared patient characteristics and real-world outcomes in 2 distinct high-risk cohorts of patients with serious mental illness (SMI), including patients with a hospitalization related to SMI (recently discharged) and patients newly diagnosed with SMI (early episode). The research included 51,705 patients with bipolar disorder, major depressive disorder, and schizophrenia.
Avalere Publishes Manuscript on Validating Preparation for Shared Decision-Making Tool for Advanced Breast Cancer Patients
Avalere’s “Preparation for Shared Decision-Making” (PFSDM) tool aims to help patients with advanced breast cancer (ABC) feel prepared to communicate with their clinicians and engage in decision making aligned with their preferences. The validation study confirms the acceptability and usability of the tool for women with ABC.
Adapting and Validating a Tool to Guide People with Stage III Non-Small Cell Lung Cancer
Avalere used a human-centered design approach to adapt a patient-centered tool to help patients prepare to make treatment decisions with their clinicians.
Digital Health is Here to Stay—Get Engaged
With increasing legislative and regulatory activity promoting adoption of digital health, interest has continued to expand in 2019.
Avalere Publishes Viewpoint on Personalizing Value in Cancer Care
To achieve the goals of value-based care, the patient voice must be incorporated into clinical decision-making by embedding shared decision-making (SDM) as a routine part of clinical practice.
More Medicare Beneficiaries Are Initiated on Direct Oral Anticoagulants According to a Recent Avalere Analysis
New Avalere analysis evaluates the trends in baseline patient characteristics among Medicare fee-for-service beneficiaries with stand-alone Part D coverage who initiated a direct oral anticoagulant during the period 2013–2017.
Get the Most Out of In-Home Assessments to Retain Members and Improve Health Outcomes
As health plans evaluate more efficient ways to engage and retain members, they should focus on existing high-touch points to improve healthcare access and the overall experience. Augmenting these efforts can generate more evidence-based patient management thus improving overall health outcomes.
Avalere Releases Recommendations to Drive More Patient Orientation in Value Assessment Methodology
Avalere published a white paper outlining global recommendations to increase the patient centricity of value assessment framework methodology and application.
Comparing the Effectiveness of New Versus Established Multiple Sclerosis Therapies in the Managed Medicaid Population
Avalere experts recently presented their research, “Comparison of Healthcare Utilization Among Managed Medicaid Individuals Diagnosed with Multiple Sclerosis Treated with Emergent vs. Established Disease-Modifying Therapy in the US.”
Avalere Research and Expertise to be Featured at AMCP and ISPOR Conferences
In the coming months, Avalere experts will be presenting new data and research at major conferences, featuring insights derived from Inovalon’s Medical Outcomes Research for Effectiveness and Economics Registry (MORE2 Registry®).
Opportunities for Real-World Data Will Grow as Big Tech Embraces Healthcare Partnerships
Partnerships between traditional healthcare players and big technology companies seek to improve care delivery and patient outcomes in innovative ways.